Club MX’s Jett Reynolds suffered a broken leg while practicing and will sit out the rest of the Supercross Series.

Robert John Cadger, from Aberdeen, headed to Italy on Saturday, March 8 for a four-day holiday to enjoy the football.

The champions from one year ago flexed their muscles at the snowmobile snocross race at ERX Motor Park on March 7-8.

Also Big Bass leaders in both divisions. (AAA-Ascension Area Anglers; AB-Atchafalaya Bassmasters; PBBC-Poor Boys Bass Club; WB-Westside Bassmasters; LAL-at large; LVBC-Lake Verret Bass Club ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...

“We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will provide an ...

The stock has a day's high of $1.83. Organovo today announced that Eli Lilly and Company (NYSE:LLY) ("Lilly") will acquire Organovo's FXR program, including its lead asset, FXR314. "This is a ...

Organovo Holdings, Inc. announced that it will be acquired by Eli Lilly and Company, which includes Organovo's FXR program and its lead asset, FXR314, aimed at treating inflammatory bowel disease ...

Eli Lil­ly is buy­ing Organo­vo’s far­ne­soid X re­cep­tor (FXR) ag­o­nist pro­gram, which in­cludes a drug in Phase 2 de­vel­op­ment for ul­cer­a­tive col­i­tis and meta­bol ...

SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotech firm specializing in 3D human tissue models, has reached an agreement to sell its FXR program, including the lead asset FXR314 ...

Organovo (ONVO) Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314. Under this transaction, Organovo will receive an ...

“We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will ...